Metraipolis › archive › dc_d6fbe85bc8a7
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42602164
- DOI
- 10.3389/fphar.2026.1864897
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T06:59:49.520Z
- SHA-256 of the archived text
d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad- Stable URL of this page
https://metraipolis.com/documento/dc_d6fbe85bc8a7
How to cite
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164 — Europe PMC (en), https://europepmc.org/article/MED/42602164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6fbe85bc8a7 (Metraipolis archive dc_d6fbe85bc8a7, sha256 d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad)
BibTeX
@misc{dcd6fbe85bc8a7,
title = {Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42602164},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6fbe85bc8a7; sha256 d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602164. Agents can read the archived copy with the MCP tool read_document.